Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

Mennini, FS, Marcellusi, A, Fabiano, G, Platini, F and Bossi, P (2019) Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer. Head & Neck, 41(4), pp. 908-914. ISSN (print) 1043-3074

Full text available as:
[img]
Preview
Text
Marcellusi-A-42736-AAM.pdf - Accepted Version

Download (1MB) | Preview
Item Type: Article
Research Area: Health services research
Faculty, School or Research Centre: Kingston Business School
Kingston Business School > Department of Accountancy, Finance and Informatics
Depositing User: Andrea Marcellusi
Date Deposited: 04 Mar 2019 14:53
Last Modified: 24 Jan 2020 03:05
DOI: https://doi.org/10.1002/hed.25481
URI: http://eprints.kingston.ac.uk/id/eprint/42736

Actions (Repository Editors)

Item Control Page Item Control Page